Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Fish and Richardson
McKesson
Medtronic
Healthtrust

Generated: August 19, 2019

DrugPatentWatch Database Preview

Zileuton - Generic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What are the generic sources for zileuton and what is the scope of zileuton freedom to operate?

Zileuton is the generic ingredient in three branded drugs marketed by Rising and Chiesi Usa Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for zileuton. Three suppliers are listed for this compound.

Pharmacology for zileuton
Synonyms for zileuton
()-1(1-Benzo[b]thien-2-ylethyl)-1-hydroxyure
(+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea
(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea
(+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea
(+/-)-N-hydroxy-N-(1-benzo[b]thien-2-ylethyl)urea
1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea
1-(1-benzothiophen-2-ylethyl)-1-hydroxy-urea
1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea
1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea
111406-87-2
133305-01-8
154003-29-9
406Z872
A 64077
A-64077
AB0012645
AB00639921_10
AB00639921_11
AB00639921-06
AB00639921-08
AB00639921-09
AB2000112
Abbot 64077
Abbott 64077
ABBOTT-64077
ABT-077
AC-13198
AC1L1TCB
ACM1189878769
ACMC-1C7JU
ACMC-20n1mn
ACMC-20n2ac
AKOS000280127
AKOS016340558
AN-33562
ANW-61226
API0004645
AX8157141
BB 0261152
BB_NC-02714
BBL029070
BC205769
BCP16199
BDBM50000541
BRD-A56359832-001-04-6
BS0262
C-14011
C11H12N2O2S
CAS-111406-87-2
CC-35698
CCG-100901
CCG-213571
CHEBI:10112
CHEMBL93
CPD000466377
CS-1563
CTI-02
CTK4B8213
D00414
DB00744
DSSTox_CID_3752
DSSTox_GSID_23752
DSSTox_RID_77185
DTXSID9023752
FT-0082368
FT-0601582
GTPL5297
HMS2051M20
HMS2089J12
HMS2093H06
HMS2235O04
HMS3369I17
HMS3393M20
HMS3654J08
HMS3714E07
HY-14164
J-002574
J-525169
J90033
K-0925
KS-1195
Leutrol
LS-158908
MCULE-7670046922
MFCD00866097
MLS000759510
MLS001424079
MLS006011971
MolPort-003-850-877
MRF-0000030
MWLSOWXNZPKENC-UHFFFAOYSA-N
N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea
N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-urea
n-(1-benzo[b]thien-2-ylethyl)-n-hydroxyurea
N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea
NC00151
NCGC00159453-02
NCGC00159453-03
NCGC00159453-04
NCGC00159453-05
NCGC00159453-06
NCGC00255046-01
NSC-730712
NSC-759277
NSC730712
NSC759277
Pharmakon1600-01505906
Prestwick0_001090
PubChem14804
RL00465
RTC-070927
s1443
SAM001246738
SB19083
SBI-0206869.P001
SC-15991
SCHEMBL18251470
SCHEMBL4209
SMR000466377
SR-01000759349
SR-01000759349-4
SR-01000759349-5
SR-01000759349-6
ST24036965
STL373010
SW197531-3
TC-070927
Tox21_111680
Tox21_111680_1
Tox21_301148
Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-
Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-, (+-)-
Urea, N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-
Urea,N-(1-benzo[b]thien-2-ylethyl)-N'-hydroxy-
Z1551429725
Zileuton (USP/INN)
Zileuton [USAN:INN:BAN]
Zileuton [USAN:USP:INN:BAN]
Zileuton, >=98% (HPLC)
Zileuton, commercially available as 600 mg tablets
Zileuton, United States Pharmacopeia (USP) Reference Standard
Zileutonum
Zileutonum [INN-Latin]
Ziluton
Zyflo
Zyflo (TN)
Zyflo CR
Zyflo Filmtab

US Patents and Regulatory Information for zileuton

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007 AB RX Yes Yes   Try a Free Trial   Try a Free Trial   Try a Free Trial
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-001 Dec 9, 1996 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Rising ZILEUTON zileuton TABLET, EXTENDED RELEASE;ORAL 204929-001 Mar 17, 2017 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-003 Dec 9, 1996 RX Yes Yes   Try a Free Trial   Try a Free Trial   Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for zileuton

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007   Try a Free Trial   Try a Free Trial
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-003 Dec 9, 1996   Try a Free Trial   Try a Free Trial
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007   Try a Free Trial   Try a Free Trial
Chiesi Usa Inc ZYFLO CR zileuton TABLET, EXTENDED RELEASE;ORAL 022052-001 May 30, 2007   Try a Free Trial   Try a Free Trial
Chiesi Usa Inc ZYFLO zileuton TABLET;ORAL 020471-001 Dec 9, 1996   Try a Free Trial   Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Daiichi Sankyo
Moodys
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.